Please login to the form below

Not currently logged in
Email:
Password:

belinostat

This page shows the latest belinostat news and features for those working in and with pharma, biotech and healthcare.

AZ signs two more deals in cancer immunotherapy

AZ signs two more deals in cancer immunotherapy

The latter is in the same class as Merck &Co's Zolinza (vorinostat), Novartis' Farydak (panobinostat) and Spectrum Pharmaceuticals' Beleodaq (belinostat), which are approved for various haematological cancers.

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Spectrum appoints chief medical officer Spectrum appoints chief medical officer

    Dr Allen will lead the development of the US-based biotech's pipeline of products, including its investigational cancer drug belinostat, which is due to be filed for approval in

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics